Latest Capital Expenditure News

Page 49 of 146
Cyprium Metals unveils a rapid restart plan for its Nifty Copper Complex, backed by a substantial A$80 million capital raise to fund early cash flow and long-term growth. The project boasts a pre-tax NPV of A$1.1 billion, positioning Cyprium as a compelling copper play on the ASX.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Moho Resources has secured the Bush Chook Gold Project in Western Australia’s Pilbara region, covering 225 square kilometres with promising high-grade gold anomalies. The company plans an aggressive exploration campaign to unlock the project’s potential, which remains untested by drilling.
Maxwell Dee
Maxwell Dee
28 Aug 2025
SomnoMed delivered a strong FY25 performance with revenue climbing 22% to $111.5 million and EBITDA turning positive at $9.2 million, boosted by operational improvements and FDA clearance of its Rest Assure device. The company projects further growth in FY26 with expanded manufacturing and ongoing innovation.
Ada Torres
Ada Torres
28 Aug 2025
RPM Automotive Group reported a mixed FY25 with a slight revenue decline but improved profitability and launched a tyre recycling initiative signaling a strategic shift.
Victor Sage
Victor Sage
28 Aug 2025
SomnoMed has delivered a standout FY25 with revenue and EBITDA exceeding market expectations, driven by strong regional growth and operational improvements. The company is now expanding capacity and advancing its innovative Rest Assure device.
Ada Torres
Ada Torres
28 Aug 2025
SomnoMed Limited reported a record FY25 with $111.5 million revenue and a return to positive EBITDA, marking a milestone of over one million patients treated globally. The company secured FDA clearance for its Rest Assure® compliance tracking device and provided optimistic guidance for FY26.
Ada Torres
Ada Torres
28 Aug 2025
Lynas Rare Earths reported FY25 results featuring record NdPr output and the first commercial heavy rare earths production outside China, alongside a $750 million equity raise to fund its ambitious Towards 2030 growth strategy.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Lynas Rare Earths reports FY25 revenue growth amid profit decline, completes major capital projects, and launches a $750 million equity raise to fund its expansive Towards 2030 strategy.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Lynas Rare Earths reported a 20% revenue increase in FY25 driven by higher NdPr sales, yet net profit fell sharply amid ramp-up costs and market challenges. The company completed key growth projects and unveiled its Towards 2030 strategy focused on downstream expansion.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Westgold Resources has transformed into a top five Australian gold producer following its merger with Karora Resources, delivering record gold production and declaring a 3-cent final dividend.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Ramsay Health Care reported a modest 1.7% increase in underlying net profit for FY25, driven by strong Australian and UK hospital performances despite significant impairments in the UK. The company is advancing its multi-year transformation and expects EBIT growth in Australia for FY26, though challenges remain.
Ada Torres
Ada Torres
28 Aug 2025
Ramsay Health Care posted solid revenue growth driven by its Australian and UK hospital businesses, despite a significant impairment charge impacting net profit. The group advances a multi-year transformation focusing on operational efficiency and capital discipline.
Ada Torres
Ada Torres
28 Aug 2025